Date of Foundation


We're building an AI for life sciences, focusing on KOL network mapping and content suggestions.

The Idea origin story

Our innovative platform uses AI technology to assist life sciences companies in establishing and understanding Key Opinion Leader (KOL) networks. It meticulously maps out KOL influence, tracks online behavior, and provides AI-curated content recommendations matched to the KOL's specific influence and online presence patterns. Our startup embodies the future of content agencies, offering tailor-made engagement strategies for each KOL, based on their unique influence and journey.

The Mission

Empowering life sciences companies with AI for bespoke KOL engagement, with comprehensive influence mapping and customized content recommendations.


Medical affairs teams at pharma and biotech companies

Problems we solve

Client’s problem

Dedicated agencies charge a premium for content creation and influence mapping, wasting valuable resources and providing no actionable insights

Confirmation of problem

The high-cost traditional agencies continually drain resources without supplying actionable, personalized KOL strategies.


Our AI solution maps KOL influence networks and generates critical insights, eliminating costly agencies while offering clarity on KOL influence, saving time and resources.

Our technologies

This solution is based on technologies

My startup leverages AI for life sciences, focusing on mapping Key Opinion Leader (KOL) networks and customizing content suggestions. We provide a platform that assists companies in unraveling KOL networks while tracking online behaviors, ensuring personalized engagement strategies based on their unique influence and patterns. Our mission is to empower these companies with bespoke KOL engagements through detailed influence mapping and tailored content recommendations. Primarily our customers consist of medical affairs teams from pharma and biotech companies who seek cost-effective yet enterprise-grade

How it works

Our patent-pending model tracks KOL influence in real-time, assessing audience reach and topical impact with digital and scientific data.

Value for the client

We streamline KOL engagement for Pharma/Biotech, leveraging AI to map influence and curate content - saving time & money, boosting strategies.

Market and strategy

Market size



We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal


% of the market

Is our goal in the next 3 years


My name’s

Lusine Kodagolian

My key role in the product

My key role is the founder of our startup, and I am responsible for executing its vision while guiding the overall business strategy.

Team size and key members

You might consider adding a product manager for strategic decisions, and a tech lead to ensure seamless technology integration.



Our chief competitors include H1, Iqvia, Veeva Link, Gramener. Each has developed their own solution of KOL mapping solutions for the Life Sciences industry

Our Advantages

Unique formula to assess KOL's influence in real-time based on both digital and scientific data, AI-driven personalized content recommendations, comprehensive peer network and relationship dynamics analysis, predictive algorithms that predict which HCPs are more likely to engage with the brand and convert

Business model

Software as a service annual contracts, with optional services components


We've successfully integrated artificial intelligence in our quest to assimilate scientific data, marking substantial progress in our product development.

Leveraging our refined predictive analytics, AI-based content suggestions, and visually appealing interface, all supported by a committed tech squad, we're poised to intensify the marketing of our software.


Over the past year, we've onboarded two major enterprise clients with contracts extending into 2024, reflecting our traction in securing and sustaining high-value partnerships.


Our company incorporated in


Key risks

We're pioneering an AI-powered platform for life sciences, focusing on mapping Key Opinion Leader (KOL) networks and personalized content tips. We aim to empower medtech companies by offering our tech solution that meticulously traces KOL influence and recommends relevant content based on their online activity patterns, thus saving time and resources usually wasted via traditional agencies. Our primary customers are medical affairs teams at pharma and biotech firms. Main risks include potential issues with data privacy or rapid changes in AI technology.




We raised investments

Our Investors

Friends and family

Rising Investments



Currently, we are raising investments



Estimated pre-investment valuation of the company

We’re looking for a co-founders

Open positions



Additional information